Home
June 2008 July 2008 August 2008
Su Mo Tu We Th Fr Sa
Week 27 1 2 3 4 5
Week 28 6 7 8 9 10 11 12
Week 29 13 14 15 16 17 18 19
Week 30 20 21 22 23 24 25 26
Week 31 27 28 29 30 31

Hyperaldosteronism (Conn’s Syndrome) Show Comments PDF Print E-mail
  
Friday, 07 April 2006

Diagnosis

Signs and Symptoms

  • Mild hypertension
  • Muscular weakness due to low potassium
  • Polyuria and polydipsia
  • Absence of edema
  • Minimal retinal vascular changes

Laboratory Diagnosis

  • Unprovoked hypokalemia is the hallmark of primary hypoaldosteronism
    • Monitoring of the potassium after salt loading with 10 g of sodium/day minimizes the false-negative normokalemic finding
    • Elevated 24-hour urine potassium excretions verifies renal potassium loss
  • Low PRA following sodium restriction distinguishes primary hyperaldosteronism from secondary hyperaldosteronism due to renal disease and elevated renin secretions (high PRA)
  • Elevated plasma or urinary aldosterone level indexed against urinary sodium excretion after potassium repletion and sodium loading taken together with a low PRA verifies the diagnosis

Tests to Delineate Adenoma and Hyperplasia

  • With posture, both PRA and plasma aldosterone rise in patients with hyperplasia. Aldosterone does not rise in patients with an adenoma
  • C-18 Cortisol methyl oxygenated metabolites are only elevated in patients with an adenoma
  • Adrenal vein aldosterone-Cortisol ratio is unilaterally elevated in patients with an adenoma, bilaterally elevated in patients with hyperplasia

Adrenal Imaging

  • Adrenal thin cut pre- and post-contrast CT
    • Adenoma: unilateral hypodense usually small, 0.5 to 2 cm
    • Hyperplasia bilateral nodular thickening

Treatment

  • Adenoma: pre-treat with spironolactone to normalize potassium, then laparoscopic adrenalectomy
  • Hyperplasia: medical management with spironolactone 50 to 200 mg/day (also calcium channel blockers are useful)
    • With asymmetric aldosterone secretion by sampling, unilateral adrenalectomy may be necessary if medical treatment fails

References

  • Blumenfeld JD, Schlusse, Sealey JE, et al: Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med, 121:877-885, 1994.
  • Blumenfeld JD, Vaughan ED Jr.: The adrenals. In: Campbell's Urology. 7th Ed. Philadelphia, Saunders, 1998, pp. 2915-2971.
  • Manger WM, Gifford RW Jr.: Pheochromocytoma. A clinical review. In: Hypertension Pathophysiology, Diagnosis, and Management. Laragh JH, Brenner BM, eds. 1995, pp. 2225-2246.
  • Orth DN: Cushing syndrome. N Eng J Med 332:791-795, 1995.
  • Ulchaker JC, Goldfarb DA, Bravo EL, Novick AC: Successful outcomes in pheochromocytoma surgery in the modern era. J Urol 161:764-767, 1999. Vaughan ED Jr.: Adrenal surgery. F. F. Marshall, Ed. In: Textbook of Operative Surgery. Philadelphia, Saunders, 1996, p 220-230.
  • Vaughan ED Jr., (ed): Diagnosis and treatments of adrenal disorders. World J Urol 17:1064, 1999.

Reader Comments

Please log-in or register in order to submit comments.

Powered by AkoComment!

 
User Rating: / 1
PoorBest


 
Visitor Ratings:
Patients:
5 (1 votes)